Apatinib: all 412 studies that test it
Page 5 of 5. Open to participants first (94), then studies with results posted, then the rest; newest registration first within each.
- Apatinib as Maintenance Therapy After First-line Chemotherapy(DC for 4 Cycles) in Postoperative Recurrence/Metastasis Progressive Gastric CancerStatus unknownNCT02509806Phase 2/3
- A Study of Apatinib Versus Docetaxol Patients With Advanced Gastric CancerStatus unknownNCT02409199Phase 2/3
- Study of Apatinib as 3rd/4th Line Treatment in Patients With Advanced Non-Squamous Non-small Cell Lung Cancer Harboring Wild-type Epidermal Growth Factor Receptor (EGFR)Status unknownNCT02332512Phase 3
- A Study of Apatinib in Non-triple-negative Metastatic Breast CancerCompletedNCT01653561Phase 2
- Dose Finding and Pharmacokinetics/Pharmacodynamics Study of Apatinib in the Treatment of Advanced Colorectal CancerCompletedNCT01531777Phase 2
- Dose-Escalation and Safety Trial of YN968D1CompletedNCT01497704Phase 1/2
- Apatinib in the Treatment of Advanced Non-squamous Non-small Cell Lung CancerStatus unknownNCT01287962Phase 3
- A Study of Apatinib in Patients With Advanced Non-squamous and Non-small Cell Lung CancerCompletedNCT01270386Phase 2
- A Study of Apatinib in Patients With Advanced Hepatocellular CarcinomaCompletedNCT01192971Phase 2
- Study of Apatinib in Metastatic Triple-Negative Breast Cancer PatientsCompletedNCT01176669Phase 2
- Apatinib Versus Placebo as a Third Line Treatment in Patients With Advanced or Metastatic Gastric CancerCompletedNCT00970138Phase 2/3
- Study of Apatinib as an Inhibitor of Tumor AngiogenesisStatus unknownNCT00633490Phase 1